|
ZNF223 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.1137999999542E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02589999999114E-05 |
| Normal-vs-Stage2 |
9.848100E-04 |
| Normal-vs-Stage3 |
1.7463800000006E-05 |
| Normal-vs-Stage4 |
7.32839999795232E-08 |
| Stage1-vs-Stage2 |
7.193000E-01 |
| Stage1-vs-Stage3 |
4.758200E-02 |
| Stage1-vs-Stage4 |
1.775710E-04 |
| Stage2-vs-Stage3 |
2.551600E-01 |
| Stage2-vs-Stage4 |
1.047840E-02 |
| Stage3-vs-Stage4 |
1.655980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.3287000002551E-07 |
| Normal-vs-AfricanAmerican |
5.657300E-03 |
| Normal-vs-Asian |
8.597500E-02 |
| Caucasian-vs-AfricanAmerican |
1.199380E-01 |
| Caucasian-vs-Asian |
6.452000E-01 |
| AfricanAmerican-vs-Asian |
9.302400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.43220000040579E-07 |
| Normal-vs-Female |
6.296200E-03 |
| Male-vs-Female |
4.175700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.200500E-04 |
| Normal-vs-Extreme_Weight |
1.63659999996568E-06 |
| Normal-vs-Obese |
7.584800E-04 |
| Normal-vs-Extreme_Obese |
2.462800E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.244000E-01 |
| Normal_Weight-vs-Obese |
7.880000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.536800E-01 |
| Extreme_Weight-vs-Obese |
1.325830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.606600E-01 |
| Obese-vs-Extreme_Obese |
4.850400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.836500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.965900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.31630000002703E-06 |
| Normal-vs-Age(81-100Yrs) |
3.68390000000662E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.875200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.311600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.084620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.504790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.018100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.165600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.99839999999574E-05 |
| Normal-VS-Type2 PRCC |
7.92809995431298E-09 |
| Normal-VS-KIRP CIMP |
5.79869999999261E-05 |
| Normal-VS-Unclassified PRCC |
2.574400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.179410E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.192100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.181600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.838600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.183900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.178810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00560000052086E-07 |
| Normal-vs-N1 |
4.1354000000049E-05 |
| Normal-vs-N2 |
1.10056408431092E-12 |
| N0-vs-N1 |
9.709400E-01 |
| N0-vs-N2 |
3.2122999999995E-06 |
| N1-vs-N2 |
1.196560E-03 |
|
|
